Searched for
AURO VACCINES
Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%For the past six months, headlines have obsessed over the Nifty moving below 25,000 or crossing 26,000. But does this in any way matter to ...
- With the tariff threat headache over, time to focus on them again? 8 pharma stocks with upside potential of up to 39%With a clear indication that no additional or special tariff will be imposed by the US on generic drugs, there is a sense of relief among I...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccineAurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for developing a pentav...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- These 5 pharma stocks can give more than 24% returns in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- Nifty Midcap Select: Are analyst projections an indication of an impending correction?Corrections or what a phase of profit booking is something which is very common and healthy in the markets. The question is whether the cor...
- Aurobindo Pharma shares jump 6% on reports of nod to launch cancer drug RevlimidOn Wednesday, Aurobindo Pharma's wholly owned subsidiary Auro Vaccines Private Limited informed about entering into a License Agreement wit...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Aurobindo Pharma's arm to invest around Rs 300 crore for biologics manufacturing facilitiesThe board of directors of CuraTeQ Biologics Pvt Ltd, at its meeting held on Thursday, approved the expansion of its operations by establish...
- Aurobindo Pharma expects to commercialise vaccine facility by Apr-MayThe Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatme...
- SGX Nifty up 20 points; here's what changed for market while you were sleepingEven as the index has risen for seven straight sessions, there are chances that the index may scale towards 12,850 level. That said, the sh...
- Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccineAurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate ...
- COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary A...
- Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC fundingIn November 2019, Aurobindo Pharma said its subsidiary Auro Vaccines LLC entered into a pact to acquire certain business assets from Profec...
- Mynvax, IIsc-incubated startup looks at Covid-19 vaccine in 18 monthsThe startup, incubated at the Indian Institute of Science, Bengaluru, also said it was critical to build capability to produce the vaccine ...
- Two more local drug companies join the race for coronavirus vaccineHyderabad-based Auro Vaccines and Pune’s Gennova Biopharmaceuticals are the latest to enter the fray, people in the know told.
Load More
